Article Text

Download PDFPDF

18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
  1. B B Chin,
  2. R L Wahl
  1. Johns Hopkins School of Medicine, Department of Radiology, Division of Nuclear Medicine, Baltimore, USA
  1. Correspondence to:
    Dr B Chin, Duke University School of Medicine, PO Box 3949, Duke University Medical Center, Durham, NC 27710;


Positron emission tomography with 18F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.

  • positron emission tomography
  • 18F-Fluoro-2-deoxyglucose
  • PET, positron emission tomography
  • FDG, 18F-fluoro-2-deoxyglucose
  • CT, computed tomography
  • CEA, carcinoembryonic antigen

Statistics from


  • Conflicts of interest: RLW has research agreement with GE Medical Systems and Siemens Medical Systems. RLW has received honorariums from GE Medical Systems, Siemens Medical Systems, Phillips, and Mobile Pet Systems. RLW is a stockholder in CTI-MI.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.